Lactate, PCho and GPC can potentially be imaged noninvasively in vivo using MRS, and may therefore be valuable biomarkers for early monitoring of response to PI3K inhibition in basal-like breast cancer. This evidence concerns the gene PIK3CA and breast cancer.